SciClone Pharmaceuticals Partners with JD Healthcare to Pioneer Integrated Immune Health Management Model
SciClone Pharmaceuticals Inc (HKG: 6600) announced a strategic partnership agreement with JD Healthcare (HKG: 6618),...
HKG: 6618
Eli Lilly & JD Health Form Digital Care Alliance for Obesity, Diabetes, and Alopecia
Eli Lilly (NYSE: LLY) China has announced a strategic partnership with JD Health (HKG: 6618)...
Bayer and JD Health Collaborate on Dulcolax-Lactulose to Expand China’s Digestive-Health Market
Bayer (ETR: BAYN) and JD Health (HKG: 6618) have launched Dulcolax-branded lactulose in a pioneering...
Innovent Biologics and JD Health Form Strategic Partnership to Enhance Drug Supply and Healthcare Services
China-based Innovent Biologics Inc., (HKG: 1801) and JD Health International Inc., (HKG: 6618) have officially...
JD Healthcare Reports 25.5% Revenue Growth in Q1 2025
JD Healthcare (HKG: 6618), a subsidiary of China’s e-commerce giant JD.com (NASDAQ: JD), released its...